1 January 2024 false No description of principal activity Taxfiler 2024.6 11058540business:PrivateLimitedCompanyLtd2024-01-012024-12-31 110585402023-12-31 110585402024-01-012024-12-31 11058540business:AuditExempt-NoAccountantsReport2024-01-012024-12-31 11058540business:FilletedAccounts2024-01-012024-12-31 110585402024-12-31 11058540business:Director12024-01-012024-12-31 11058540business:RegisteredOffice2024-01-012024-12-31 11058540core:WithinOneYear2024-12-31 11058540core:ShareCapitalcore:PreviouslyStatedAmount2024-12-31 11058540core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-12-31 11058540core:PreviouslyStatedAmount2024-12-31 11058540business:SmallEntities2024-01-012024-12-31 11058540countries:EnglandWales2024-01-012024-12-31 11058540core:AdditionsToInvestments2024-12-31 11058540core:AfterOneYear2024-12-31 iso4217:GBP xbrli:pure
Company Registration No. 11058540 (England and Wales)
LIPOCUBE BIO TECHNOLOGY LIMITED Unaudited accounts for the year ended 31 December 2024
LIPOCUBE BIO TECHNOLOGY LIMITED Unaudited accounts Contents
Page
- 2 -
LIPOCUBE BIO TECHNOLOGY LIMITED Company Information for the year ended 31 December 2024
Director
Kemal Tunc Tiryaki
Company Number
11058540 (England and Wales)
Registered Office
C/O IRWIN MITCHELL LLP RIVERSIDE EAST 2 MILLSANDS SHEFFIELD SOUTH YORKSHIRE S3 8DT
- 3 -
LIPOCUBE BIO TECHNOLOGY LIMITED Statement of financial position as at 31 December 2024
2024 
Notes
£ 
Fixed assets
Investments
779,753 
Current assets
Debtors
189,531 
Cash at bank and in hand
707 
190,238 
Creditors: amounts falling due within one year
(472,315)
Net current liabilities
(282,077)
Net assets
497,676 
Capital and reserves
Called up share capital
584,875 
Profit and loss account
(87,199)
Shareholders' funds
497,676 
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 17 July 2025 and were signed on its behalf by
Kemal Tunc Tiryaki Director Company Registration No. 11058540
- 4 -
LIPOCUBE BIO TECHNOLOGY LIMITED Notes to the Accounts for the year ended 31 December 2024
1
Statutory information
LIPOCUBE BIO TECHNOLOGY LIMITED is a private company, limited by shares, registered in England and Wales, registration number 11058540. The registered office is C/O IRWIN MITCHELL LLP RIVERSIDE EAST, 2 MILLSANDS, SHEFFIELD, SOUTH YORKSHIRE, S3 8DT.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Investments
Subsidiary undertakings 
£ 
Valuation at 1 January 2024
- 
Additions
779,753 
Valuation at 31 December 2024
779,753 
5
Debtors
2024 
£ 
Amounts falling due within one year
Trade debtors
680 
Accrued income and prepayments
(79,300)
Other debtors
259,089 
180,469 
Amounts falling due after more than one year
Amounts due from group undertakings etc.
9,062 
6
Creditors: amounts falling due within one year
2024 
£ 
VAT
(539)
Trade creditors
1,293 
Other creditors
471,560 
Loans from directors
1 
472,315 
- 5 -
LIPOCUBE BIO TECHNOLOGY LIMITED Notes to the Accounts for the year ended 31 December 2024
7
Average number of employees
During the year the average number of employees was 0.
- 6 -